M. Docteur HUGO MOREL

Bibliographie

• COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

  2021

  ArticleThe Lancet Rheumatology

• Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

  2020

  ArticleAnnals of the Rheumatic Diseases

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Localisation

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieu de consultation

• CABINET DU DR HUGO MOREL

  8E RUE JEANNE BARRET, 21000 Dijon

  Libéral
  © OpenStreetMap

  📷 Street View ↗🗺️ Maps ↗OSM ↗

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Articles de presse (2)

Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).

• Nouveau label pour l'hôpital : recrutement de nouveaux soignants, offre de soins améliorée, projets... ce que ça change - Le Bien Public

  📰 Le Bien Public · 22/09/2022

  <a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNRkpRVzV3M1V6X0R2ZTVtRkFSSHdZcmEtdlFlZ21uZmdzcDN3VVZkX1VxVlNGbDQxdDJXTDZXM19VTXNpY2g2cTJSOUo0YjFrMG9ITVg0MkhvTFR3ZUZ4WXNfN3NyWGc3ZUx1ZW83MTZ0bVdvZzl1VXFDT05Tajh4bERvM3JMaktUV0lrQUE0OHZVUQ?oc=5" target="_blank">Nouveau label pour l'hôpital

• Auxonne. Le centre hospitalier labellisé hôpital de proximité - Le Bien Public

  📰 Le Bien Public · 18/05/2022

  <a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQMFV0MDY1aTNubHFBZi1fbHlzbFZBN052SEM0ZFg3Qm1XUmY4MW14OVRCLTBISWQ1OWlQek5xamJCVDlKa0s4MXRVQl9pUVdQWHRFNFhMdWJ4M28tajdnc1RzRVRGb1djZFhaN2FCcW5CUjZpM3hlOUZTTEw2Um9rWDZxM2hvMEpqUlhWa0tBX0ZxSWNuQWFtZDFzTzVxZnhVdlpudmJjbUY?oc=5" target="_blank">

Top publications · les plus citées

• 1

  Comorbidities of COPD

  European respiratory review : an official journal of the European Respiratory Society · 2013

  📚 377 citations🎯 RCR 14.69Top 1% NIH🔓 Open Access

  Lire l'abstract Crossref ↓

  By 2020, chronic obstructive pulmonary disease (COPD) will be the third cause of mortality. Extrapulmonary comorbidities influence the prognosis of patients with COPD. Tobacco smoking is a common risk factor for many comorbidities, including coronary heart disease, heart failure and lung cancer. Comorbidities such as pulmonary artery disease and malnutrition are directly caused by COPD, whereas others, such as systemic venous thromboembolism, anxiety, depression, osteoporosis, obesity, metabolic syndrome, diabetes, sleep disturbance and anaemia, have no evident physiopathological relationship with COPD. The common ground between most of these extrapulmonary manifestations is chronic systemic inflammation.All of these diseases potentiate the morbidity of COPD, leading to increased hospitalisations and healthcare costs. They can frequently cause death, independently of respiratory failure. Comorbidities make the management of COPD difficult and need to be evaluated and treated adequately.

• 2

  Women and COPD: do we need more evidence?

  European respiratory review : an official journal of the European Respiratory Society · 2019

  📚 111 citations🎯 RCR 6.90Top 5% NIH🔓 Open Access📄 PDF gratuit ↗

  Lire l'abstract Crossref ↓

  The increasingly female face of chronic obstructive pulmonary disease (COPD) prevalence among women has equalled that of men since 2008, due in part to increased tobacco use among women worldwide and exposure to biomass fuels. This finding is supported by a number of characteristics. There is evidence of susceptibility to smoking and other airborne contaminants, along with epidemiological and phenotypic manifestations. COPD has thus become the leading cause of death in women in the USA. The clinical presentation is characterised by increasingly pronounced dyspnoea with a marked tendency towards anxiety and depression, undernutrition, nonsmall cell lung cancer (especially adenocarcinoma) and osteoporosis. Quality of life is also more significantly impacted. The theories advanced to explain these differences involve the role played by oestrogens, impaired gas exchange in the lungs and smoking habits. While these differences require appropriate therapeutic responses (smoking cessation, pulmonary rehabilitation, long-term oxygen therapy), barriers to the treatment of women with COPD include greater under-diagnosis than in men, fewer spirometry tests and medical consultations. Faced with this serious public health problem, we need to update and adapt our knowledge to the epidemiological changes.

• 3

  [Comorbidities of COPD]

  Revue de pneumologie clinique · 2015

  📚 7 citations

Publications scientifiques (8) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche